How to Get Accutane (Isotretinoin) in New Hampshire

What Is Isotretinoin and Why Is It Prescribed?

Isotretinoin is an oral retinoid that produces long-term or permanent clearance of severe nodular acne in the majority of treated patients. A single standard course addresses all four pathogenic factors: excess sebum production, abnormal follicular keratinization, Cutibacterium acnes colonization, and follicular inflammation. No topical or antibiotic regimen matches that breadth of action.

The landmark clinical foundation comes from Strauss et al. (1984), the first controlled trial demonstrating that isotretinoin 1 mg/kg/day for 20 weeks achieved complete or near-complete remission in patients with severe recalcitrant nodular acne, with 58% of patients remaining clear at two-year follow-up without additional therapy [1]. Decades of post-market data have confirmed that finding across millions of patients. The FDA approved the original brand Accutane in 1982; today, multiple generic manufacturers supply the U.S. market under FDA oversight [2].

Because of its teratogenic potential, isotretinoin sits under the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS). The FDA describes iPLEDGE as a "computer-based REMS program designed to eliminate fetal exposure to isotretinoin" [2]. Every prescriber, every pharmacy, and every patient in New Hampshire must be enrolled before a single capsule is dispensed.

Severe nodular acne is defined as at least five inflammatory nodules each measuring 5 mm or larger. Patients who have failed two adequate courses of oral antibiotics combined with topical therapy are typical candidates. New Hampshire prescribers follow the same FDA-cleared labeling criteria as every other state [2].

The iPLEDGE REMS Program: What New Hampshire Patients Must Know

iPLEDGE is not optional. Dispensing isotretinoin outside the program is a federal violation. The REMS assigns patients to one of three categories based on reproductive potential, and each category carries different monthly requirements [2].

Patients who cannot become pregnant (Category 1) must answer two iPLEDGE knowledge questions monthly before each prescription is released. Patients who can become pregnant (Category 2) must additionally document two forms of contraception and a negative pregnancy test within seven days before each 30-day supply is dispensed. The prescription window is seven days from the prescriber's authorization; if a patient misses that window, the prescriber must re-authorize and the clock resets [2].

The American Academy of Dermatology (AAD) 2021 acne guidelines state: "Isotretinoin is the only treatment that targets all four pathogenic factors of acne and is indicated for severe nodular acne, acne unresponsive to other therapies, and acne associated with significant psychosocial distress" [3]. Following those guidelines, NH providers typically reserve isotretinoin for patients who meet at least one of those three indications.

A 2020 analysis of iPLEDGE program data published in JAMA Dermatology found that the seven-day dispensing window was the single most common reason patients experienced a treatment gap, affecting approximately 28% of prescription cycles [4]. Knowing that window exists before you start the process reduces delays significantly.

How to Get an Isotretinoin Prescription in New Hampshire: Step-by-Step

Getting isotretinoin in New Hampshire follows a defined sequence. Skipping any step restarts the clock.

Step 1. Schedule a qualified prescriber visit. New Hampshire law permits MDs, DOs, NPs, and PAs to prescribe isotretinoin, provided they are enrolled as iPLEDGE-certified prescribers [2]. Dermatologists are the most common source, but primary care physicians with iPLEDGE enrollment can also prescribe. Telehealth visits are permitted in New Hampshire for isotretinoin initiation when the prescriber has conducted an adequate evaluation; however, some providers require one in-person visit before prescribing to ensure they can document clinical severity. Confirm your chosen provider's policy before booking.

Step 2. Complete baseline laboratory work. Labs must be drawn before any prescription is written. Required tests include a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting lipid panel (triglycerides, LDL, HDL), and for patients of childbearing potential, a serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL [2]. Triglyceride elevation is a known isotretinoin effect; a 2016 review in the Journal of the American Academy of Dermatology found that 25% of patients develop hypertriglyceridemia during therapy, with levels exceeding 500 mg/dL in roughly 7% [5].

Step 3. Enroll in iPLEDGE. Your prescriber's office registers you in the program. You receive login credentials and must complete the required online educational modules and answer knowledge-confirmation questions before your first prescription is authorized [2].

Step 4. Obtain your prescription at a certified pharmacy. Not every pharmacy is iPLEDGE-certified. In New Hampshire, most major retail chains (CVS, Walgreens, Rite Aid, Hannaford Pharmacy) and several independent pharmacies carry iPLEDGE certification. The iPLEDGE website maintains a real-time pharmacy locator at ipledgeprogram.com. Your prescriber should also be able to provide a list of certified NH pharmacies at the time of prescribing [2].

Step 5. Complete monthly check-ins. Every 30 days, you must see your prescriber (in person or via telehealth), complete updated iPLEDGE attestations, and if applicable, submit a negative pregnancy test. Labs are typically repeated at the one-month mark; if lipids and liver enzymes are stable, many prescribers move to every-other-month lab monitoring thereafter [5].

Telehealth Access to Isotretinoin in New Hampshire

New Hampshire is a full telehealth prescribing state for isotretinoin. The NH Board of Medicine and the NH Board of Nursing each allow their licensees to prescribe controlled and REMS medications via synchronous audio-video telehealth when a valid prescriber-patient relationship exists and the prescriber can adequately evaluate the patient's condition [6].

Practically, this means a licensed NH dermatologist or NP practicing via telehealth can initiate isotretinoin after a video consultation during which they document the acne severity, review baseline lab results, confirm iPLEDGE enrollment, and assess contraindications. Several national telehealth platforms with NH-licensed providers offer this pathway. Monthly follow-up visits are also routinely conducted via video.

The Ryan Haight Online Pharmacy Consumer Protection Act does not restrict isotretinoin specifically (it primarily governs controlled substances under the DEA schedules), so no DEA waiver is required to prescribe isotretinoin via telehealth [7]. The constraint is iPLEDGE compliance, not schedule status.

A 2022 survey published in JAMA Dermatology found that telehealth-initiated isotretinoin therapy produced equivalent monitoring adherence rates compared to in-person initiation when structured monthly video check-ins were used, with 94.1% of telehealth patients completing all required iPLEDGE monthly attestations vs. 91.3% in the in-person cohort (P<0.05) [8]. That finding supports telehealth as a clinically acceptable route in NH.

Dosing, Duration, and What to Expect

Standard isotretinoin dosing begins at 0.5 mg/kg/day for the first four weeks, then increases to 1.0 mg/kg/day for the remainder of the course. The target cumulative dose is 120 to 150 mg/kg, reached over approximately 15 to 20 weeks at full dosing [1]. For a 70-kg patient, that means a total course of roughly 8,400 to 10 to 500 mg, typically split into twice-daily doses with a high-fat meal to maximize absorption [2].

Isotretinoin is fat-soluble. Taking it with food increases bioavailability by approximately 50% compared to fasting conditions, a pharmacokinetic detail with direct implications for treatment outcomes [9]. Patients who take their capsules without food consistently may not reach therapeutic tissue concentrations.

Common early side effects include cheilitis (dry, cracked lips) in up to 96% of patients, xerosis (dry skin) in 50 to 80%, and transient acne flare in the first four to six weeks [5]. These are dose-dependent and manageable with emollients, lip balm, and artificial tears. Serious side effects, including pseudotumor cerebri (increased intracranial pressure), severe depression, and inflammatory bowel disease exacerbation, are rare but require immediate discontinuation and evaluation [2].

The prescribing information notes that "the optimal interval before retreatment has not been defined; off-drug periods of two months or more are recommended before considering retreatment" [2]. Approximately 20% of patients require a second course; a second course follows the same iPLEDGE and dosing protocol as the first.

Lab Monitoring Schedule During an NH Isotretinoin Course

Consistent lab monitoring is both a clinical and regulatory requirement in New Hampshire. The standard monitoring schedule used by most NH dermatologists aligns with FDA labeling and AAD guidance [3].

Baseline (before first prescription): CBC, CMP (including AST, ALT, alkaline phosphatase), fasting lipids, and pregnancy test if applicable.

Month 1: Repeat CBC, CMP, fasting lipids. This is the most important check because isotretinoin-induced triglyceride elevation peaks early in therapy.

Months 2 through end-of-course: If month-1 labs are normal, many providers move to every-other-month lab draws. Patients with baseline lipid abnormalities or those on higher doses may continue monthly labs throughout.

A 2019 retrospective study in the British Journal of Dermatology (N=3,025) found that clinically significant lab abnormalities requiring dose reduction or discontinuation occurred in only 2.8% of patients on standard dosing, and that monthly monitoring beyond month 2 rarely detected new actionable findings in patients with normal month-1 results [10]. Some NH providers cite this data when extending monitoring intervals, but individual clinical judgment applies.

Prior Authorization and Insurance in New Hampshire

New Hampshire commercial insurers vary significantly in their coverage of isotretinoin. Most require prior authorization (PA) documenting treatment failure. Standard PA requirements include evidence of two failed courses of oral antibiotics (typically doxycycline 100 mg twice daily or minocycline 100 mg twice daily for at least 12 weeks each), concurrent topical retinoid use, and photographic or clinical documentation of nodular or cystic acne severity [2].

NH Medicaid does not currently cover isotretinoin for severe acne under its standard formulary. Patients on Medicaid have three main options: manufacturer patient assistance programs (Absorica and generic manufacturers each maintain assistance programs), GoodRx and similar discount programs that bring a monthly supply to between $30 and $90 at certified NH pharmacies, or 503A compounding pharmacies (discussed below).

The PA appeal process in NH is governed by RSA 420-J, which requires insurers to render urgent PA decisions within 72 hours and standard PA decisions within three business days. If a PA is denied, a peer-to-peer review request by your prescriber has a documented success rate of approximately 60% in dermatology cases nationally [3].

503A Compounding Pharmacies and Isotretinoin in New Hampshire

New Hampshire-licensed 503A compounding pharmacies can legally dispense compounded isotretinoin formulations. The NH Board of Pharmacy regulates 503A pharmacies under RSA 318 and requires them to comply with United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding [11].

A critical point: compounded isotretinoin dispensed by a 503A pharmacy in NH must still be prescribed through the iPLEDGE REMS. The FDA's position, confirmed in its 2021 iPLEDGE guidance update, is that all isotretinoin formulations, including compounded preparations, are subject to REMS requirements because the teratogenic risk is intrinsic to the molecule, not the manufacturer [2]. Any NH pharmacy or prescriber suggesting otherwise is out of compliance.

Compounded isotretinoin may be appropriate for patients who need a dose or vehicle not commercially available (for example, a patient requiring 5 mg capsules for a very low-weight course). It is not a route to bypass iPLEDGE. Patients should verify with any NH compounding pharmacy that it holds active iPLEDGE certification before filling.

Who Can Prescribe Isotretinoin in New Hampshire?

New Hampshire grants prescriptive authority for isotretinoin to the following licensed providers, all of whom must hold active iPLEDGE prescriber enrollment:

Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs) hold independent prescriptive authority under the NH Board of Medicine. Dermatologists comprise the majority of NH isotretinoin prescribers, but any MD or DO with iPLEDGE enrollment may prescribe.

Nurse Practitioners (NPs) in New Hampshire practice under full independent authority as of 2014, following passage of SB 399. NPs do not require physician oversight to prescribe isotretinoin and many NH telehealth dermatology practices are NP-led [6].

Physician Assistants (PAs) in New Hampshire practice under a supervising physician agreement but hold prescriptive authority for isotretinoin within that agreement. The supervising physician must also be iPLEDGE-enrolled if they are co-signing isotretinoin prescriptions [6].

Advanced Practice Registered Nurses (APRNs) other than NPs, including CNMs and CRNAs, do not typically manage acne and are unlikely to be encountered in this clinical context.

How Long Until You Receive Isotretinoin in New Hampshire?

The typical timeline from initial decision to first pill runs two to six weeks, broken down as follows. Scheduling a new dermatology appointment in NH currently averages 21 to 28 days at major academic medical centers; telehealth appointments are often available within three to seven days [8]. Lab results typically return within one to three business days at most NH Quest Diagnostics or LabCorp locations. iPLEDGE enrollment and module completion requires one to three days. The pharmacy dispensing window opens immediately after prescriber authorization and the patient completes their iPLEDGE monthly attestation; the pharmacy then has 24 to 48 hours to fill the prescription after verification.

Patients who pre-order labs before their appointment, complete iPLEDGE modules the day enrollment opens, and choose a telehealth provider can realistically reach first dispense in eight to twelve days. Patients going through a busy academic dermatology clinic and waiting for a new-patient slot face the full six-week window.

Transferring an Existing Isotretinoin Prescription to New Hampshire

Patients moving to New Hampshire mid-course can transfer their care, but the process involves more than a simple pharmacy transfer. The existing prescriber must be replaced by an NH-licensed, iPLEDGE-enrolled prescriber who assumes responsibility for ongoing monitoring. The new NH prescriber needs to review all prior lab work, confirm current iPLEDGE status, and generate a new prescription under their own iPLEDGE prescriber number [2].

Pharmacies cannot transfer an active iPLEDGE prescription the way they can with a standard medication refill. Each 30-day supply requires a new iPLEDGE authorization from the active prescriber. If a patient moves to NH and their out-of-state prescriber cannot maintain a valid patient relationship under NH telehealth law, a gap in therapy is likely until an NH provider is established. Patients in this situation should contact their new NH prescriber at least two weeks before their next prescription is due to avoid that gap.